Literature DB >> 33357433

Ribosome 18S m6A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth.

Bowen Rong1, Qian Zhang2, Jinkai Wan1, Shenghui Xing1, Ruofei Dai1, Yuan Li3, Jiabin Cai1, Jiaying Xie1, Yang Song1, Jiawei Chen4, Lei Zhang1, Guoquan Yan1, Wen Zhang1, Hai Gao1, Jing-Dong J Han4, Qianhui Qu1, Honghui Ma5, Ye Tian6, Fei Lan7.   

Abstract

N6 methylation at adenosine 1832 (m6A1832) of mammalian 18S rRNA, occupying a critical position within the decoding center, is modified by a conserved methyltransferase, METTL5. Here, we find that METTL5 shows strong substrate preference toward the 18S A1832 motif but not the other reported m6A motifs. Comparison with a yeast ribosome structural model unmodified at this site indicates that the modification may facilitate mRNA binding by inducing conformation changes in the mammalian ribosomal decoding center. METTL5 promotes p70-S6K activation and proper translation initiation, and the loss of METTL5 significantly reduces the abundance of polysome. METTL5 expression is elevated in breast cancer patient samples and is required for growth of several breast cancer cell lines. We further find that Caenorhabditis elegans lacking the homolog metl-5 develop phenotypes known to be associated with impaired translation. Altogether, our findings uncover critical and conserved roles of METTL5 in the regulation of translation.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  18S; ER-UPR; METTL5; S6K; decoding center; lifespan; m6A1832; rRNA modification; ribosome; translation initiation

Mesh:

Substances:

Year:  2020        PMID: 33357433     DOI: 10.1016/j.celrep.2020.108544

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  21 in total

1.  N6-methyladenosine (m6A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation.

Authors:  Hao Peng; Binbin Chen; Wei Wei; Siyao Guo; Hui Han; Chunlong Yang; Jieyi Ma; Lu Wang; Sui Peng; Ming Kuang; Shuibin Lin
Journal:  Nat Metab       Date:  2022-08-23

2.  Prognostic value of comprehensive typing based on m6A and gene cluster in TNBC.

Authors:  Haoming Wu; Jikun Feng; Jundong Wu; Wenjing Zhong; Xiazi Zouxu; Weiling Huang; Xinjian Huang; Jiarong Yi; Xi Wang
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-15       Impact factor: 4.322

Review 3.  METTLing in Stem Cell and Cancer Biology.

Authors:  John G Tooley; James P Catlin; Christine E Schaner Tooley
Journal:  Stem Cell Rev Rep       Date:  2022-09-12       Impact factor: 6.692

Review 4.  The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer.

Authors:  Lin Luo; Yingwei Zhen; Dazhao Peng; Cheng Wei; Xiaoyang Zhang; Xianzhi Liu; Lei Han; Zhenyu Zhang
Journal:  Cell Death Discov       Date:  2022-07-18

Review 5.  The emerging importance of METTL5-mediated ribosomal RNA methylation.

Authors:  Elena M Turkalj; Caroline Vissers
Journal:  Exp Mol Med       Date:  2022-10-21       Impact factor: 12.153

Review 6.  Biological roles of adenine methylation in RNA.

Authors:  Konstantinos Boulias; Eric Lieberman Greer
Journal:  Nat Rev Genet       Date:  2022-10-19       Impact factor: 59.581

7.  Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.

Authors:  Hua Liu; Guangzhen Qin; Yanan Ji; Xiaojian Wang; Hailin Bao; Xiaojun Guan; Aichun Wei; Zhigang Cai
Journal:  J Orthop Surg Res       Date:  2021-05-05       Impact factor: 2.359

Review 8.  Regulation of Ribosome Function by RNA Modifications in Hematopoietic Development and Leukemia: It Is Not Only a Matter of m6A.

Authors:  Francesco Fazi; Alessandro Fatica
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

9.  Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.

Authors:  Jianfeng Zheng; Jialu Guo; Benben Cao; Ying Zhou; Jinyi Tong
Journal:  Cancer Cell Int       Date:  2021-07-08       Impact factor: 5.722

Review 10.  Crosstalk between N6-methyladenosine modification and circular RNAs: current understanding and future directions.

Authors:  Xin Wang; Rui Ma; Xilin Zhang; Lian Cui; Yangfeng Ding; Weimin Shi; Chunyuan Guo; Yuling Shi
Journal:  Mol Cancer       Date:  2021-09-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.